SUMMARY In a prospective study of 70 unselected patients with chronic liver disease, clinical signs of a peripheral neuropathy were observed in 13 patients. Abnormal nerve conduction was demonstrated in nine of these and in one further patient who had no abnormal neurological signs. The occurrence of a neuropathy (in patients with cryptogenic cirrhosis, haemochromatosis, active chronic hepatitis as well as in alcoholic cirrhosis) could not be related to liver function, although it was associated with higher IgA and IgM values. Clinical diabetes was present in six of the 14 patients with neuropathy but there was no relation in the non-diabetic patients between neuropathy and minor impairment of carbohydrate tolerance. Those with neuropathy had a significantly higher incidence of oesophageal varices and there was also a relationship to a history of previous encephalopathy. Sural nerve biopsy was carried out on 14 patients, eight of whom had clinical or electrodiagnostic evidence of neuropathy. Single nerve fibres were examined by teasing and in all nerves histological evidence was found of an indolent process which had damaged whole Schwann cells and which resulted in demyelination and remyelination. Diabetic angiopathy was not seen and axonal degeneration, which was never severe, was found in all disease groups equally.
The occurrence of a demyelinating peripheral neuropathy in liver disease was first described by Dayan and Williams (1967) . Six of their 10 patients had clinical signs of nerve damage including absent reflexes and impairment of vibration sense or touch, although a biopsy of the sural nerve showed active segmental demyelination in all. This type of Schwann cell disease also occurs in the neuropathy of diabetes and other conditions Gilliatt, 1969; Dayan, Gardner-Thorpe, Down, and Gleadle, 1970) , but is distinct from the histological changes of axonal degeneration usually seen in alcoholism (Victor, 1965) . The cause of the segmental demyelination observed in the patients with liver disease was not established and the present study was undertaken to determine the frequency of peripheral nerve damage in a larger series of patients who were investigated by electrodiagnostic techniques as well as clinically and by sural nerve biopsy. A possible relationship to the biochemical changes, including disturbances of carbohydrate metabolism, which accompany liver disease was also examined.
METHODS
Seventy patients (36 males, 34 females) with histologically proven cirrhosis or active chronic hepatitis were questioned for symptoms indicative of peripheral neuropathy-namely, distal sensory loss, paraesthesiae, clumsiness, or weakness. Examination of the peripheral nervous system included the appreciation of light touch, pinprick, and two-point discrimination. Alteration in vibration sense was sought by timing the duration of perception of a tuning fork (frequency 128/sec) placed on the olecranon, second metacarpophalangeal joint, tibial tubercles, and medial malleoli. Isolated loss or reduction of ankle jerks in patients more than 60 years old was not considered abnormal.
The laboratory investigations included a blood count and liver function tests, and in 48 patients the serum immunoglobulins. In the first 23 patients serum B12 and folate levels were measured and the bone marrow examined. An oral glucose tolerance test (50 g load) was also carried out except in those patients known to be diabetic.
ELECTRODIAGNOSTIC TECHNIQUES Nerve conduction velocities were measured in both lateral popliteal nerves stimulating at the head of the fibula and at the ankle. Velocities were also obtained for the upper and lower segments of left median and ulnar nerves by stimulating at the axilla, elbow, and wrist. Bipolar electrodes of 8 mm diameter carrying a square electrical pulse of 01 msec duration were used for stimulation, and for recording surface electrodes were placed over the extensor digitorum brevis muscle in the foot, and the thenar and hypothenar muscles in the hand. Electromyograms were obtained from a concentric needle electrode inserted into the first dorsal interosseous muscle in each hand, and in the tibialis anterior and extensor digitorum brevis muscle in each foot. The temperature of the examination room was more than 65°F (18-3°C). The electrodiagnostic investigations were carried out without knowledge of the clinical findings.
Peripheral neuropathy was considered to be present if there was significant slowing of motor nerve conduction in one nerve (30 m/sec in the lateral popliteal nerves, and 40 in/sec in the median or ulnar nerves). Spontaneous fibrillation and positive potentials in the electromyogram with the muscle at rest, and a reduced interference pattern on maximal voluntary effort were regarded as evidence of denervation but were not considered diagnostic of a neuropathy unless slowing of motor nerve conduction was also present.
RESULTS
Clinical signs of neuropathy were found in 13 of the 70 patients, although only two complained of paraesthesiae and weakness. The most common abnormalities were impairment of vibration sense in the legs-present in 13 patients-and impairment of superficial sensation in a 'glove and stocking' distribution which was found in seven patients. The ankle reflexes were absent on both sides or obtainable only with reinforcement in seven patients, in four of whom there was also impairment or absence of knee jerks. Motor weakness of the limbs (M.R.C. grade 4) was found in five patients.
Nine of these patients with clinical neuropathy also showed electrodiagnostic evidence of neuropathy. In Neuropathy was found most frequently in alcoholic cirrhosis and haemochromatosis (Table  2 ) but the numbers in some of the aetiological groups were relatively small. None of the patients with haemochromatosis had had a history of significant alcohol intake. The patient with the most severe neuropathy had active chronic hepatitis, and is described in more detail later.
A comparison of those with and without neuropathy revealed no significant differences in the liver function tests except for changes in serum immunoglobulins (Table 3 The severity of the neuropathy bore no relationship to the duration of diabetes. In four patients diabetes had been diagnosed more than 10 years previously, whereas in the other two patients with an equally severe neuropathy diabetes had been present for only six months. Both of these patients had also had episodes of portosystemic encephalopathy, which may have contributed to their neuropathy. Of the 56 patients without neuropathy four had diabetes, a significantly lower incidence (P <00 1).
Sixteen of the patients who did not have clinical diabetes were found to have an impaired glucose tolerance test (defined as a two-hour blood sugar level higher than 120 mg/100 ml.). In each case the fasting level was below 100 mg/ 100 ml. One had a neuropathy and 15 did not, giving a similar incidence in both groups of patients. Comparison of the patients with a raised two-hour blood sugar level and those with a normal level revealed no significant differences in nerve conduction velocities, latencies, or vibration perception times (Table 4) The data for the internodal-length relationship in four patients has been plotted for each fibre according to the convention of Fullerton, Gilliatt, Lascelles, and Morgan-Hughes (1965) , in which individual segments on an isolated fibre are represented by points on a vertical line (Fig. 2) . Comparison with normal values Dayan and Williams (1967) Cavanagh and Kyu, 1969) . Not surprisingly this correlates with periods of encephalopathy and this aetiological relationship is further supported by the improvement in conduction velocities seen in case 1 during protein restriction.
In one series of cirrhotic patients from Great
Britain, diabetes was present in 32% and abnormal glucose tolerance was found in a further 25% of patients (Megyesi, Samols, and Marks, 1967) . The impairment of glucose tolerance is associated with relative hyperinsulinism but the exact cause is unknown. Although in our patients there was a higher incidence of neuropathy in those with clinical diabetes than in those without, there was no correlation between neuropathy and minor abnormalities of glucose tolerance. This finding is in agreement with the recent study of Seneviratne and Peiris (1970) who showed that electrodiagnostic evidence of neuropathy was common in a group of patients with chronic liver disease selected because of a normal glucose tolerance test. Advancing age is itself associated with clinical (Mayne, 1965) and pathological evidence (Lascelles and ) of damage to peripheral nerves for reasons which are not known. In the present series 13 of the 18 patients with neuropathy were less than 60 years old, the age beyond which 'physiological' nerve damage becomes apparent clinically. Furthermore, the severity of the clinical signs and the extent of the nerve lesions in some of the older patients were greater than could be due to ageing alone (Arnold and Harriman, 1970) .
There was no relationship between the occurrence of neuropathy and the duration of liver disease, or the changes in liver function tests. The high IgA and IgM levels are of interest but the association may simply indicate that neuropathy is related to an 'active' stage of cirrhosis as illustrated by case 2. In this patient the neuropathy improved on corticosteroid treatment simultaneously with improvement in the biochemical changes of active chronic hepatitis. Other organs including skin, lungs, and colon are not infrequently involved in this condition, such multi-system involvement implying an 'abnormal immune system' in this patient. The findings in case 2 would suggest that the peripheral nerves can be added to the list of organs sometimes involved in this disease. Alternatively, the immunoglobulin abnormalities may be more directly related to the cause of the nerve damage, for neuropathy is found in patients with various types of paraproteinaemias (Logothetis, Kennedy, Ellington, and Williams, 1968) and is common in patients with myeloma (Morley and Schwieger, 1968) . Unfortunately, the histological appearances themselves give no clue to the aetiology of the neuropathy in our patients, although they do suggest that the final common path is Schwann cell damage.
